FINWIRES · TerminalLIVE
FINWIRES

Austem to Retire KRW4.35 Billion in Treasury Shares

By

Austem (KOSDAQ:031510) plans to retire 2.91 million treasury shares, valued at 4.35 billion won.

The shares will be retired on June 5 at a par value of 500 won apiece, according to a Tuesday filing from the South Korean automobile parts manufacturer on the Korea Exchange.

Shares of Austem fell nearly 1% in recent trade.

Related Articles

Asia

WuXi Biologics to Conduct Up to $400 Million Share Buyback; Shares Up 4%

WuXi Biologics (Cayman) (HKG:2269) said it plans to buy back up to $400 million of its shares from the open market, according to a filing with the Hong Kong bourse.The company said its current share price does not reflect its intrinsic value, representing a good opportunity to conduct the buyback.The company's shares were up over 4% in recent morning trade.

$HKG:2269
Asia

DL E&C Reports Worker Fatality at S-Oil's Shaheen Project in Ulsan

DL E&C (KRX:375500) disclosed the death of a worker at S-Oil's (KRX: 010950) Shaheen petrochemical project in Ulsan, according to a Tuesday regulatory filing with the Korea Exchange.DL E&C is part of a consortium, alongside Hyundai E&C and Hyundai Engineering, responsible for carrying out the project's core Package One. This phase covers the construction of the site's steam cracker and thermal crude-to-chemicals facilities.The worker's body was discovered seated at the very bottom of a drum at the construction site. Local police and the Ministry of Employment and Labor are expected to conduct an on-site inspection and establish measures to prevent a recurrence, the filing said.Shares of DL E&C and S-Oil rose more than 1% in recent trade.

$KRX:010950$KRX:375500
Asia

SSY Group Gets Bulk Drug Approval for Parkinson's Disease Treatment in China

SSY Group (HKG:2005) obtained registration approval for Safinamide Mesylate to become a bulk drug for the preparations on the market from China's National Medical Products Administration, according to a Tuesday Hong Kong bourse filing.The drug is mainly used for the treatment of Parkinson's disease in combination with other Parkinson's drugs such as levodopa, the filing said.

$HKG:2005